{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:34:58Z","timestamp":1787589298274,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Joint Key Program of Zhejiang Province-Ministry of Health"},{"DOI":"10.13039\/501100017538","name":"Ten-Thousand Talents Plan of Zhejiang Province","doi-asserted-by":"crossref","award":["2021R52020"],"award-info":[{"award-number":["2021R52020"]}],"id":[{"id":"10.13039\/501100017538","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.prnil.2025.06.001","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T02:13:40Z","timestamp":1749435220000},"page":"219-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Burden of prostate cancer in China during 1990\u20132021 and the projections through 2050"],"prefix":"10.1016","volume":"13","author":[{"given":"Lei","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijiao","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xukai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4677-0361","authenticated-orcid":false,"given":"Tianhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.prnil.2025.06.001_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca - Cancer J Clin"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40779-021-00354-z","article-title":"Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019","volume":"8","author":"Zi","year":"2021","journal-title":"Military Medical Research"},{"issue":"5","key":"10.1016\/j.prnil.2025.06.001_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin Med J (Engl Ed)"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib4","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"4","key":"10.1016\/j.prnil.2025.06.001_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1200\/JCO.2024.42.23_suppl.201","article-title":"Current screening stategies for prostate cancer and expert consensus of Chinese prostate cancer screening [In Chinese]","volume":"31","author":"Li","year":"2024","journal-title":"Chin J Clin Oncol Rehabil"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1186\/s12885-022-10244-9","article-title":"Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.prnil.2025.06.001_bib7","doi-asserted-by":"crossref","first-page":"853623","DOI":"10.3389\/fendo.2022.853623","article-title":"Burden of prostate cancer in China, 1990-2019: findings from the 2019 global burden of disease study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"10440","key":"10.1016\/j.prnil.2025.06.001_bib8","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet (Lond Engl)"},{"issue":"10440","key":"10.1016\/j.prnil.2025.06.001_bib9","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet (Lond Engl)"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib10","doi-asserted-by":"crossref","first-page":"12740","DOI":"10.1038\/s41598-024-63191-9","article-title":"Time trends in the mortality of testicular cancer across the BRICS: an age-period-cohort analysis for the GBD 2019","volume":"14","author":"Xu","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.prnil.2025.06.001_bib11","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/587154","article-title":"The intrinsic estimator for age-period-cohort analysis: what it is and how to use it","volume":"113","author":"Yang","year":"2008","journal-title":"Am J Sociol"},{"issue":"2","key":"10.1016\/j.prnil.2025.06.001_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03610920008832483","article-title":"Ridge estimator in singulah oesiun with application to age-period-cohort analysis of disease rates","volume":"29","author":"Fu","year":"2000","journal-title":"Commun Stat Theor Methods"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib13","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1186\/s12889-021-11401-8","article-title":"Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and Joinpoint analysis","volume":"21","author":"Guo","year":"2021","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.prnil.2025.06.001_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: bayesian age\u2013period\u2013cohort analysis with integrated nested laplace approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4111\/icu.20230247","article-title":"Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999\u20132020","volume":"65","author":"Cho","year":"2024","journal-title":"Investig Clin Urol"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib16","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA, Chart Account (Tor)"},{"issue":"2","key":"10.1016\/j.prnil.2025.06.001_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cac2.12627","article-title":"Cancer situation in China: an analysis based on the global epidemiological data released in 2024","volume":"45","author":"Diao","year":"2025","journal-title":"Cancer Commun"},{"issue":"6","key":"10.1016\/j.prnil.2025.06.001_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and prevention of prostate cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.prnil.2025.06.001_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.prnil.2024.08.001","article-title":"The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey","volume":"12","author":"Chen","year":"2024","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2025.06.001_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.habitatint.2012.09.007","article-title":"Evolution and assessment on China\u2019s urbanization 1960\u20132010: under-urbanization or over-urbanization?","volume":"38","author":"Chen","year":"2013","journal-title":"Habitat Int"},{"issue":"24","key":"10.1016\/j.prnil.2025.06.001_bib21","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"137","author":"Wu","year":"2024","journal-title":"Chin Med J (Engl)."},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2018.293514","article-title":"Perspective on prostate cancer screening","volume":"65","author":"Carlsson","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.prnil.2025.06.001_bib23","doi-asserted-by":"crossref","first-page":"215927","DOI":"10.1016\/j.canlet.2022.215927","article-title":"Prostate cancer treatment \u2013 China\u2019s perspective","volume":"550","author":"Liu","year":"2022","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.juro.2016.08.103","article-title":"Prostate-specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies in comparison with western cohorts: data from the PBCG and CPCC","volume":"197","author":"Chen","year":"2017","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.prnil.2025.06.001_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun"},{"issue":"2","key":"10.1016\/j.prnil.2025.06.001_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2019.04.033","article-title":"Structured population-based prostate-specific antigen screening for prostate cancer: the european association of urology position in 2019","volume":"76","author":"Gandaglia","year":"2019","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2025.06.001_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4111\/icu.20230229","article-title":"Prostate-specific antigen screening for prostate cancer: an old but never-ending story","volume":"64","author":"Kim","year":"2023","journal-title":"Investig Clin Urol"},{"issue":"2","key":"10.1016\/j.prnil.2025.06.001_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.7326\/0003-4819-157-2-201207170-00459","article-title":"on behalf of the U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. preventive services task force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1016\/j.prnil.2025.06.001_bib29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.prnil.2025.06.001_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European association of urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.prnil.2025.06.001_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/15579883231161292","article-title":"Using \u201cage and total-PSA\u201d as the main indicators: the results of taizhou integrated prostate screening (no 2)","volume":"17","author":"Zhu","year":"2023","journal-title":"Am J Mens Health"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/aja.2008.21","article-title":"Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China","volume":"11","author":"Zhang","year":"2009","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib33","article-title":"The impact of prostate-specific antigen screening on prostate cancer incidence and mortality in China: 13-year prospective population-based cohort study","volume":"10","author":"Ruan","year":"2024","journal-title":"JMIR Public Health Surveillance"},{"key":"10.1016\/j.prnil.2025.06.001_bib34","first-page":"1","article-title":"China guideline for the screening and early detection of prostate cancer(2022,Beijing)[In Chinese]","volume":"31","author":"He","year":"2022","journal-title":"China Cancer"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40779-024-00569-w","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi","year":"2024","journal-title":"Military Medical Research"},{"issue":"11","key":"10.1016\/j.prnil.2025.06.001_bib36","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s11427-022-2240-6","article-title":"Overview and countermeasures of cancer burden in China","volume":"66","author":"Wang","year":"2023","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1016\/j.prnil.2025.06.001_bib37","article-title":"Current cancer situation in China: good or bad news from the 2018 global cancer statistics?","volume":"39","author":"Rm","year":"2019","journal-title":"Cancer Commun"},{"issue":"7","key":"10.1016\/j.prnil.2025.06.001_bib38","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1470-2045(20)30073-5","article-title":"Cancer registration in China and its role in cancer prevention and control","volume":"21","author":"Wei","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888225000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:25:07Z","timestamp":1765434307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888225000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2287888225000443"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2025.06.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of prostate cancer in China during 1990\u20132021 and the projections through 2050","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2025.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}